Discovery of indazole-pyridinone derivatives as a novel class of potent and selective MNK1/2 kinase inhibitors that protecting against endotoxin-induced septic shockEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92021-03-016PREAI
Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK InhibitorsCURRENT MEDICINAL CHEMISTRYIF3.52017-09-2561PREAI
Repression of tumor survival pathways by novel and selective inhibitors of MNK1 and MNK2 kinases in glioblastoma and colorectal cancerCANCER RESEARCHIF16.62014-10-011PRE
Repression of tumor survival pathways by novel, selective inhibitors of MNK1 and MNK2 kinasesCANCER RESEARCHIF16.62014-05-150PRE
Antitumor activity of SEL120: An orally available dual inhibitors of Haspin/CDK9, for standalone and combination therapy with AuroraB inhibitors in solid tumors and hematopoietic malignanciesCANCER RESEARCHIF16.62012-04-011PRE
Preclinical development of a Pim kinase inhibitor for cancer treatmentCANCER RESEARCHIF16.62012-04-010PRE
Gaining Insight into Off-Target Mediated Effects of Drug Candidates with a Comprehensive Systems Chemical Biology AnalysisJOURNAL OF CHEMICAL INFORMATION AND MODELINGIF5.32009-01-13137PRE
Virtual fragment linking: An approach to identify potent binders from low affinity fragment hitsJOURNAL OF MEDICINAL CHEMISTRYIF6.82008-03-2235PREAI
Application of an artificial neural network to predict specific class I MHC binding peptide sequencesNATURE BIOTECHNOLOGYIF41.71998-08-0167PREAI
Algorithm for rapid reconstruction of protein backbone from alpha carbon coordinatesJOURNAL OF COMPUTATIONAL CHEMISTRYIF4.81997-01-1542PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向